| Sandra Preston, PHARMD | |
|
415 Delaware Ave, Albany, NY 12209-1615 | |
| (518) 463-2986 | |
| (518) 463-1724 |
| Full Name | Sandra Preston |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 415 Delaware Ave, Albany, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144542440 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 040778-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sandra Preston, PHARMD 415 Delaware Ave, Albany, NY 12209-1615 Ph: (518) 463-2986 | Sandra Preston, PHARMD 415 Delaware Ave, Albany, NY 12209-1615 Ph: (518) 463-2986 |
News Archive
Scientists at Oregon State University have taken an important step toward gene therapy for deaf patients by developing a way to better study a large protein essential for hearing and finding a truncated version of it.
A unique and innovative telemedicine project is providing distant nursing home patients with Parkinson's disease access to neurologists at the University of Rochester Medical Center (URMC).A pilot study of the project - the results of which were released this month at the International Congress of Parkinson's Disease and Movement Disorders in Paris - demonstrates that the system can improve the quality of life and motor function of patients.
Type 2 diabetes greatly increases a person's risk of developing cardiovascular disease (CVD). A new study showing that cardiovascular risk factors such as elevated blood pressure and cholesterol levels differ significantly between men and women is published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced data from a subgroup analysis of a Phase 2 randomized discontinuation trial showing that the median progression-free survival (PFS) achieved by patients with advanced clear cell renal cell carcinoma (RCC) who had undergone a prior nephrectomy was 14.8 months.
According to a new study from the UK, transplanted kidneys from patients whose hearts have stopped perform just as well as those from patients who are brain-dead but still alive. The former have been earlier considered to be weaker since the heart had stopped pumping blood into them before transplant. The study was published online by the The Lancet.
› Verified 3 days ago
Muthuvappa Ahamed Naina, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 493 Delaware Avenue, Rite-aid #10694, Albany, NY 12209 Phone: 518-472-1206 | |
Abigail N Rudasill, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1616 | |
Dr. Michael Peter Daprano, PHARM. D, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12 Jupiter Ln, Albany, NY 12205 Phone: 518-689-2900 | |
Dr. Brian Chapin, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 53 Ormond St, Albany, NY 12203 Phone: 607-226-2277 | |
Abu Baker Durrani, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 440 Magazine St, Albany, NY 12203 Phone: 910-581-8196 | |
Maria Sobieraj, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-381-6325 | |
Michael Vennard Jr., Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2040 Western Ave, Albany, NY 12203 Phone: 518-869-0657 |